Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

ARWR

Arrowhead Pharmaceuticals, Inc. · Healthcare · Biotechnology

88.88 0.0% mkt cap $12.52B quote delayed (FMP) · as of Aug 26 14:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
16Tracked holders
+2Δ holders
54.75MShares held
$865.08MReported value
+2New positions
−0Exits
Rising Conviction score 61/100 4 quarters of rising tracked shares ●●●●○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +14.3% · share flow -0.7% · net new positions +12.5%formula
Ownership fragmentation — more holders, smaller aggregate stake

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 133 +6 82.36M $6.29B +14 −7
Q1 2026 129 +9 82.68M $4.92B +14 −6
Q4 2025 119 +2 83.16M $5.52B +3
Q3 2025 18 0 61.93M $2.14B +1 −2
Q2 2025 16 +2 54.75M $865.08M +2
Q1 2025 11 +1 14.99M $191.04M +1
Q4 2024 10 -1 13.46M $253.12M +1 −2
Q3 2024 10 +1 7.88M $152.69M +1
Q2 2024 9 6.44M $167.29M
Holder count
Who holds it · Q2 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
2 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
3 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
4 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
5 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
6 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
7 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
8 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
9 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
10 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
11 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
12 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
13 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
14 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
15 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
16 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
17 BlackRock (passive) 19.42M $306.91M 0.0% n/c 1 SEC ↗
18 The Vanguard Group (passive) 15.53M $245.30M 0.0% n/c 1 SEC ↗
19 The Vanguard Group (passive) 15.53M $245.30M 0.0% n/c 1 SEC ↗
20 The Vanguard Group (passive) 15.53M $245.30M 0.0% n/c 1 SEC ↗
21 The Vanguard Group (passive) 15.53M $245.30M 0.0% n/c 1 SEC ↗
22 The Vanguard Group (passive) 15.53M $245.30M 0.0% n/c 1 SEC ↗
23 State Street Global Advisors (passive) 6.37M -9.0% $100.66M 0.0% ▼ Trim 3 SEC ↗
24 Fidelity (FMR) 5.17M $81.69M 0.0% n/c 1 SEC ↗
25 Fidelity (FMR) 5.17M $81.69M 0.0% n/c 1 SEC ↗
26 Fidelity (FMR) 5.17M $81.69M 0.0% n/c 1 SEC ↗
27 Geode Capital Management (passive) 2.98M +1.0% $47.07M 0.0% ▲ Add 5 SEC ↗
28 Geode Capital Management (passive) 2.98M +1.0% $47.07M 0.0% ▲ Add 5 SEC ↗
29 Marshall Wace 2.16M +3507.8% $34.06M 0.0% ▲ Add 3 SEC ↗
30 Marshall Wace 2.16M +3507.8% $34.06M 0.0% ▲ Add 3 SEC ↗
31 Marshall Wace 2.16M +3507.8% $34.06M 0.0% ▲ Add 3 SEC ↗
32 Norges Bank (passive) 1.92M +6.8% $30.41M 0.0% ▲ Add 5 SEC ↗
33 Fisher Asset Management 451.65K -6.5% $7.14M 0.0% ▼ Trim 5 SEC ↗
34 Millennium Management 169.04K -75.5% $2.67M 0.0% ▼ Trim 5 SEC ↗
35 AQR Capital Management 152.35K +276.1% $2.41M 0.0% ▲ Add 2 SEC ↗
36 AQR Capital Management 152.35K +276.1% $2.41M 0.0% ▲ Add 2 SEC ↗
37 AQR Capital Management 152.35K +276.1% $2.41M 0.0% ▲ Add 2 SEC ↗
38 AQR Capital Management 152.35K +276.1% $2.41M 0.0% ▲ Add 2 SEC ↗
39 Two Sigma Investments 133.40K -84.0% $2.11M 0.0% ▼ Trim 5 SEC ↗
40 T. Rowe Price 100.61K +8.0% $1.59M 0.0% ▲ Add 5 SEC ↗
41 Arrowstreet Capital 64.20K New $1.01M 0.0% New 1 SEC ↗
42 Citadel Advisors 62.24K -93.7% $983,471 0.0% ▼ Trim 5 SEC ↗
43 Wellington Management 48.28K -8.2% $762,902 0.0% ▼ Trim 5 SEC ↗
44 Wellington Management 48.28K -8.2% $762,902 0.0% ▼ Trim 5 SEC ↗
45 Wellington Management 48.28K -8.2% $762,902 0.0% ▼ Trim 5 SEC ↗
46 Wellington Management 48.28K -8.2% $762,902 0.0% ▼ Trim 5 SEC ↗
47 Gotham Asset Management 18.86K New $298,035 0.0% New 1 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Arrowstreet Capital $1.01M 0.0%
Gotham Asset Management $298,035 0.0%

Exited

No tracked exits this quarter.

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 7 holders, 11.03M shares, $23.90M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

No open-market insider purchases in our coverage window.

Open-market sales (S)

Aug 18 OLUKOTUN ADEOYE Y

Director · 2.00K sh · $173,920

Aug 18 PERRY MICHAEL S

Director · 11.60K sh · $1.01M

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Beneficial ownership
Aug 14 SC 13G/A — Avoro Capital Advisors LLC

View original SEC filing ↗

Jul 31 SC 13G/A — VANGUARD PORTFOLIO MANAGEMENT LLC

View original SEC filing ↗

Jul 27 SC 13G/A — BlackRock, Inc.

View original SEC filing ↗

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q2 2025 · Methodology · Get this via the API